MCM
SZYM

Manchester Capital Management’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Manchester Capital Management’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-15,000
Closed -$47K – 649
2015
Q2 		$47K Buy
+15,000
New +$51.4K 0.01% 404

Other funds holding SZYM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PC
Passport Capital San Francisco, California $394M AUM 50.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Manchester Capital Management's SZYM Position: Q3 2015 in Review

Manchester Capital Management sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q3 2015, closing a stake of 15,000 shares — an estimated $47K sold.

Manchester Capital Management first reported a position in SZYM in Q2 2015 and held it in 1 quarter. The position peaked at $47K in Q2 2015. 101 funds tracked by Wall St. Rank hold SZYM as of Q3 2015.

  • Manchester Capital Management reported no remaining SOLAZYME INC COM STK (DE) position as of Q3 2015 after selling out during the quarter.
  • Manchester Capital Management sold 15,000 SOLAZYME INC COM STK (DE) shares in Q3 2015, an estimated $47K.
  • Manchester Capital Management first reported a position in SOLAZYME INC COM STK (DE) in Q2 2015 and held it in 1 quarter.
  • Manchester Capital Management's SOLAZYME INC COM STK (DE) position peaked at $47K in Q2 2015.
  • 101 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q3 2015.

Based on Manchester Capital Management's 13F filing for Q3 2015, filed 20 Oct 2015.